JPRN-UMIN000003295招募中1 期
Phase I study for the efficacy and the safety of the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia. - Phase I study for the perioperative urinastatin therapy in chest surgical patients with interstitial pneumonia
Tokyo Women's Medical University of Medicine, Department of Surgery I0 个研究点目标入组 30 人开始时间: 2010年3月6日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Having the history of allergic reaction against ulinastatin. 2.Asbestosis. 3.Chronic hypersensitivity pneumonitis. 4.Sarcoidosis. 5.Pregnancy.
研究者
相似试验
尚未招募
1 期
Investigating targEting LysyL oxIdase tO ameliorate scarring in burn Traumaburn injurySkin - Other skin conditionsInjuries and Accidents - BurnsACTRN12623001071617university of western australia60
进行中（未招募）
不适用
A study to find out whether treating patients who have liver metastases from eye melanoma with radiofrequency ablation combined with ipilimumab, will kill the tumor without them having too many adverse events.EUCTR2011-004200-38-NLKI-AV
已完成
不适用
Safety and Efficacy of the Adapt Pericardial Patch in the repair of defects associated with congenital heart disease in participants aged between 1 and 12 years of ageCongenital Heart Disease including ventricular septal defect repair, atrial ventricular septal defect, atrio ventricular septal defects as determined by clinical assessment including MRI and echo cardiographyCardiovascular - Other cardiovascular diseasesACTRN12613000308796A/Professor Christian Brizard40
尚未招募
不适用
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
终止
不适用
A phase I study to determine the efficacy and safety of CKD-516 tablet combined with durvalumab(MEDI4736) in patient refractory solid tumorsKCT0005756Asan Medical Center42